Sungju Jung
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Noncanonical EZH2 activity cooperates with FOXM1 to drive tumorigenesis and advanced progression in HCC.
Journal: Clinical and molecular hepatology
Published: December 09, 2025
Ift46 deficiency causes renal cyst via enhanced Limk2 through lack of autophagy flux.
Journal: Cell communication and signaling : CCS
Published: June 20, 2025
Decoding SPP1 regulation: Genetic and nongenetic insights into its role in disease progression.
Journal: Molecules and cells
Published: January 14, 2025
VIM-AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma.
Journal: Experimental & molecular medicine
Published: May 08, 2024
Correspondence on Editorial regarding "Identification of signature gene set as highly accurate determination of MASLD progression".
Journal: Clinical and molecular hepatology
Published: February 22, 2024
Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression.
Journal: Clinical and molecular hepatology
Published: November 01, 2023
EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer.
Journal: NAR cancer
Published: March 11, 2021
From genome sequencing to the discovery of potential biomarkers in liver disease.
Journal: BMB reports
Published: March 27, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026